Clonidine

Alternative Names: Catapres, Catapres-TTS, Duraclon, Jenloga, and Kapvay

Clonidine is a centrally acting alpha-2 adrenergic agonist that lowers blood pressure by decreasing sympathetic nervous system activity. It is typically reserved for resistant hypertension or short-term outpatient management of significantly elevated blood pressure. Due to its sedating effects, dry mouth, and risk of rebound hypertension if abruptly discontinued, clonidine is not considered a first-line therapy. It is available in oral and transdermal patch forms, with the patch offering more stable blood levels and fewer peaks and troughs. 

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Clonidine

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Clonidine is an effective treatment for hypertension, particularly in resistant or hard-to-control cases where other medications have not worked. However, it is not considered a first-line treatment due to potential side effects and the risk of rebound hypertension, making it more suitable for specific, short-term situations under medical supervision.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
4.0
1 = No Relief 5 = Immediate Relief

4.0

Fast Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
1.0
1 = Third-line or more 5 = First-line

1.0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews
5
100%
4
0%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Clonidine is an effective treatment for hypertension, particularly in resistant or hard-to-control cases where other medications have not worked. However, it is not considered a first-line treatment due to potential side effects and the risk of rebound hypertension, making it more suitable for specific, short-term situations under medical supervision.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 month ago
Clonidine is used for hypertension primarily in cases of resistant high blood pressure or for short-term outpatient control when rapid lowering is needed. It’s not a first-line choice due to side effects and risk of rebound hypertension, but it is effective when other options have failed.
#VeryAffordable #FastRelief #MildEffect #Third-lineOrMore #Maintenance #Rescue/EmergencyUse
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All